Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
Contents
- Chapter 1 Clinical presentation and assessment of disease activity in lupus nephritisVenkat Reddy and David Isenberg
- Chapter 2 Lupus nephritis: HistopathologyDavid J. Cimbaluk and Melvin M. Schwartz
- Chapter 3 Lupus nephritis: Complement in lupusMichael G. Robson
- Chapter 4 Pathogenesis of lupus nephritisN. Stanley Nahman, Jr and Michael P. Madaio
- Chapter 5 Evidence-based treatment of lupus nephritisWai Y. Tse and Dwomoa Adu
- Chapter 6 The role of biologicals in the treatment of lupus nephritisAmara N. Ezeonyeji and David A. Isenberg
- Chapter 7 Systemic lupus erythematosus (SLE) in pregnancyAisha Lateef and M. Petri
- Chapter 8 Renal involvement in the anti-phospholipid syndromeJoyce Rauch and Jerrold S. Levine
- Chapter 9 Vasculitis classificationJ. Charles Jennette, Ronald J. Falk, and Adil Hussein Gasim
- Chapter 10 The immunopathogenesis of vasculitisAndrew McClean and C.O.S. Savage
- Chapter 11 Pathology of vasculitis: Wegener's granulomatosis, microscopic polyangiitis, renal limited vasculitis, and Churg–Strauss syndromeFranco Ferrario and Maria Pia Rastaldi
- Chapter 12 Assessment of disease activity and damage in the ANCA-associated systemic vasculitidesJoanna C. Robson, Ravi Suppiah, and Raashid A. Luqmani
- Chapter 13 The clinical presentation and treatment of renal vasculitisDavid Jayne
- Chapter 14 Polyarteritis nodosa: Clinical characteristics, outcome, and treatmentLoïc Guillevin
- Chapter 15 Vasculitis (ANCA negative): Henoch–Schönlein purpuraRosanna Coppo and Alessandro Amore
- Chapter 16 Takayasu arteritisVivekanand Jha and Kirpal S. Chugh
- Chapter 17 Systemic sclerosis: Immunopathogenesis, clinical features, and treatmentVoon H. Ong and Christopher P. Denton
- Chapter 18 Amyloidosis: Immunopathogenesis and diagnosisH.J. Lachmann and P.N. Hawkins
- Chapter 19 Amyloidosis: Rheumatic disease and amyloid; clinical features and treatmentH.J. Lachmann and P.N. Hawkins
- Chapter 20 Primary amyloidosis (AL)Robert A. Kyle
- Chapter 21 Light-chain and heavy-chain deposition diseasesPierre Ronco and Pierre Aucouturier
- Chapter 22 Hepatitis C virus-associated mixed cryoglobulinaemiaEdgar D. Charles
- Chapter 23 Hepatitis B-associated renal diseasesKar Neng Lai and Sydney C.W. Tang
- Chapter 24 Rheumatic complications of HIV infectionUlrich A. Walker
- Chapter 25 Renal complications of HIV infectionSusan E. Collins, Thomas Hays, and Paul Klotman
- Chapter 26 NSAID nephrotoxicityWai Y. Tse and Dwomoa Adu
- Chapter 27 Nephrotoxicity of drugs used in rheumatology: Analgesic nephropathyMarc E. De Broe
- Chapter 28 Renal toxicity of anti-rheumatic drugsSarah Bingham and Paul Emery
- Chapter 29 Rheumatological diseases associated with interstitial nephritisAlan D. Salama and Charles D. Pusey
- Chapter 30 Management of gout in the patient with renal diseasePhilip Courtney and Michael Doherty
- Chapter 31 Nephrogenic systemic fibrosisTeresa K. Chen and Derek M. Fine1
- Chapter 32 Rheumatological complications of renal disease and transplantationSharmin Nizam, Zunaid Karim, and Paul Emery